ID   WPE1-NB26-64
AC   CVCL_K284
DR   ATCC; CRL-2889
DR   Wikidata; Q54994376
RX   PubMed=16471037;
CC   Population: Caucasian.
CC   Characteristics: Established from WPE1-NB26 cells that formed subcutaneous tumors following cell injection in athymic mice.
CC   Doubling time: ~19 hours (ATCC=CRL-2889).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2889
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3813 ! WPE1-NB26
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
RX   PubMed=16471037;
RA   Rivette A.S., Tokar E.J., Williams D.E., Mackenzie C.D., Ablin R.J.,
RA   Webber M.M.;
RT   "Selection of cell lines with enhanced invasive phenotype from
RT   xenografts of the human prostate cancer cell line WPE1-NB26.";
RL   J. Exp. Ther. Oncol. 5:111-123(2005).
//